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Neurexins are multidomain synaptic cell-adhesion
proteins that associate with multiple partnering
proteins. Genetic evidence indicates that neurexins
may contribute to autism, schizophrenia, and nico-
tine dependence. Using analytical ultracentrifuga-
tion, single-particle electron microscopy, and
solutionX-ray scattering,weobtained a three-dimen-
sional structural model of the entire extracellular
domain of neurexin-1a. This protein adopts a dimen-
sionally asymmetric conformation that is monomeric
in solution,with amaximumdimensionof170 A˚. The
extracellular domain of a-neurexin maintains a char-
acteristic ‘‘Y’’ shape, whereby LNS domains 1–4
form an extended base of the ‘‘Y’’ and LNS5-6 the
shorter arms. Moreover, two major regions of flexi-
bility are present: one between EGF1 and LNS2, cor-
responding to splice site 1, another between LNS5
and 6. We thus provide the first structural insights
into the architecture of the extracellular region of
neurexin-1a, show how the protein may fit in the
synaptic cleft, and how partnering proteins could
bind simultaneously.
INTRODUCTION
Genes encoding neuronal cell-adhesion proteins are essential
for development and maintenance of connectivity in the nervous
system. Synaptic cell-adhesion proteins constitute a principal
pathway contributing to genetic susceptibility of autism spec-
trum disorders (ASD) (Geschwind and Levitt, 2007). Emerging
evidence indicates that variations in copy number and other
rare variants within the genes encoding neurexin-1 and -3
(NRXN1 andNRXN3) contribute to ASD susceptibility andmental
retardation (Feng et al., 2006; The Autism Genome Project1044 Structure 18, 1044–1053, August 11, 2010 ª2010 Elsevier Ltd AConsortium, 2007; Kim et al., 2008; Yan et al., 2008; Glessner
et al., 2009; Zahir et al., 2008; Zweier et al., 2009).
Neurexin-1a (aNRXN1) is a neuronal cell surface receptor that
was originally identified as a high-affinity receptor for the spider
toxin a-latrotoxin, whereas NRXN2 and 3 were subsequently
identified from DNA sequence similarity with aNRXN1. Within
each NRXN gene, the presence of two promoters, a and b,
enables the expression of a longer a and a shorter bNRXN,
yielding a total of six NRXN proteins (Missler and Su¨dhof,
1998). Extensive independent alternative splicing of the encoded
proteins (Ullrich et al., 1995) could specify a code of interactions
between NRXNs and their ligands in different classes of
synapses. Moreover, alternative splicing in NRXN3 creates
a large diversity of secreted gene products, including those
encoding multiple variants with in-frame stop codons (Ushkar-
yov and Su¨dhof, 1993; Ullrich et al., 1995). Similar to the
construct used in this study, all secreted splice variants end
between the sixth Laminin, Neurexin, Sex-hormone-binding
globulin (LNS) domain and various positions before the begin-
ning of the transmembrane domain.
Currently, four groups of endogenous ligands for a and
bNRXNs have been identified: neuroligins (NLGN) (Ichtchenko
et al., 1995), neurexophilins (Missler et al., 1998), dystroglycan
(Sugita et al., 2001), and leucine-rich repeat transmembrane
proteins (LRRTM2) (de Wit et al., 2009; Ko et al., 2009). NRXNs
and NLGNs are thought to form a trans-synaptic complex
meeting near the center of the synaptic cleft, with the C-terminal
sequences of either protein extending in opposite directions,
tethering them to the pre- and postsynapticmembranes, respec-
tively (Comoletti et al., 2007; Fabrichny et al., 2007; Arac¸ et al.,
2007; Chen et al., 2008). Early studies of cell association with
neurons in cell culture suggested that NLGNs and NRXNs are
sufficient to induce formation of new synapses (Scheiffele et al.,
2000; Graf et al., 2004). In particular, all three aNRXNs induce
clustering of the GABAergic postsynaptic scaffolding protein
gephyrin and NLGN2, but not of the glutamatergic postsynaptic
scaffolding protein PSD-95 or NLGN 1/3/4 in an artificial
synapse-formation assay (Kang et al., 2008). This suggests that
aNRXNs may be mediators of GABAergic synaptic proteinll rights reserved
Figure 1. Schematic Diagram of the
aNRXN1 Constructs Used and Hydrody-
namic Characterization of the Purified
Extracellular Domain of aNRXN_1-6
(A) Top: the domain organization of full-length
aNRXN1 with respect to the pre-syanptic
membrane. The C-terminal intracellular domain is
shown to the right of the membrane, whereas the
large N-terminal region extending into the synaptic
cleft is shown on the left. Stalk, O-lined glycosy-
lated domain; E1 to E3, EGF domains. Potential
N-linked glycosylation sites are indicated using
single letter code; open arrowheads , sites alterna-
tive splicing. Bottom: the extracellular regions of
the aNRXN1 used for this study. L31, E280, and
T1309 refer to the amino acid number in the
protein sequence. The dotted line indicates
a potential center of symmetry.
(B) Size exclusion chromatography trace of puri-
fied aNRXN_1-6. Inset, Coomassie blue staining
of a sample composed of the main peak.
(C) G(s) distribution plots from the enhanced
van Holde–Weischet analysis of sedimentation
velocity experiments of two concentrations of
aNRXN_1-6.
(D) Two-dimensional spectrum/Monte Carlo anal-
ysis of the 20 nM velocity experiment. The distribu-
tion shows a single, monomeric species with a
molecular weight of 140 kDa. The blue gradient
indicates partial concentration.
(E) Concentration histogram of the globally fitted
fixed molecular weight distribution analysis of the
sedimentation equilibrium data. See also Figure S1.
Structure
Structure of the Extracellular Domain of aNRXN1recruitment and stabilization. Earlier studies of aNRXN-knockout
mice revealed only mild variations in synaptic density and ultra-
structure (Dudanova et al., 2007). More recently, a study of the
aNRXN-1 knockout showed severe impairment of excitatory
neurotransmission pathways (Etherton et al., 2009). aNRXNs
appear to play a functional role at the synapse, including medi-
ating Ca2+-triggered neurotransmitter release (Missler et al.,
2003), but do not seem toparticipate in synapse formation. These
findings suggest that the aNRXNs are a group of trans-synaptic
cell-adhesion molecules that participate in a modular organiza-
tion of presynaptic terminals bymediating the localized activation
of Ca2+ channels.
Structurally, aNRXN1 is a large (160 kDa) multidomain
protein composed of several discernable regions. A cleavable
N-terminal signal peptide is responsible for trafficking the
protein to the cell membrane. The mature protein contains
three homologous repeats, each motif composed of a central
epidermal growth factor (EGF) domain flanked upstream and
downstream by two LNS domains sharing limited protein identity
(Figure 1A). These three repeats, formed by nine independently
folded domains that span 90% of the protein sequence, areStructure 18, 1044–1053, August 11, 2010 ªfollowed by a single stalk domain that is
likely to be partially rigidified through
extensive O-linked glycosylation. The
stalk domain connects to a single trans-
membrane domain and a short cyto-
plasmic tail containing a classical PDZrecognition motif that appears to target NRXN to the presynaptic
region (Fairless et al., 2008). Although the crystal structures of
the isolated second, fourth, and sixth LNS domains of aNRXN1
have been solved (Rudenko et al., 1999; Sheckler et al., 2006;
Shen et al., 2008), the overall domain complexity of the intact
protein has been an impediment to examining structural organi-
zation beyond individual LNS domains.
Using a set of complementary biophysical techniques, we
developed a three-dimensional structural model of the entire
extracellular domain of aNRXN1 in solution. Although some
flexibility at the extremities of the extracellular domain is
detected, the overall architecture of aNRXN1 is consistent with
a semielongated protein with a stable shape resembling the
letter ‘‘Y.’’ The results reported here represent, to our knowl-
edge, the first three-dimensional structural models of the extra-
cellular domain of aNRXN super-family that include neurexin
(1 to 3) and Caspr (Contactin associated-like protein) 1 to 5.
Together, these results should facilitate the understanding of
how aNRXN might be arranged in the limited space of the
synaptic cleft and how this protein may associate with multiple
transmembrane and soluble synaptic proteins.2010 Elsevier Ltd All rights reserved 1045
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Characterization of the Purified Extracellular Domain
of aNRXN
Protein expression and N-terminal sequencing
Two constructs from the extracellular domain of aNRXN1 were
expressed as soluble entities in the cell culture medium of
HEK293 GnTI- cells: one starting at position Leu31 and encom-
passing sites of alternative splicing #1 and #3 (aNRXN_1-6)
and an N-terminal deletion devoid of the first LNS and
EGF domains to yield a protein starting at position Glu280
(aNRXN_2-6) (Figure 1A). By size exclusion chromatography,
both constructs elute as single peaks (see Figure 1B; see
Figure S1A available online), indicating the presence of homoge-
neous monomeric species. In SDS-PAGE followed by Coomas-
sie blue staining, aNRXN_1-6 and aNRXN_2-6 appear as single
bands of 140 kDa and 110 kDa (insets of Figure 1B;
Figure S1A), consistent with the calculated molecular weight of
the peptides. As we express aNRXN protein with its native leader
peptide (mgtallqrggcfllclsllllgcwaelgsgLEFPG), Edman degrada-
tion of the first five residues of the mature protein was performed
to assign the initial amino acids after the cleavage of the leader
sequence. The unambiguously determined sequence Leu-Glu-
Phe-Pro-Gly indicated that the mature protein starts at Leu31,
consistent with previous findings (Missler et al., 1998) and
sequence predictions.
Mass spectrometric analysis of aNRXN
Both aNRXN1 constructs were expressed in the culture medium
of HEK293 GnTI- cells. These cells lack N-acetylglucosaminyl-
transferase I (GnTI) activity, and consequently glycosylation
remains restricted to a homogeneous seven-residue oligosac-
charide (Reeves et al., 2002), thus simplifying structural
analyses. aNRXN1 contains four potential N-linked glycosylation
sites at positions N125, N190, N790, and N1223 (Figure 1).
Although the peptidic mass of the expressed protein is calcu-
lated to be 140,619 Da, MALDI-TOF indicated a MW value of
145,896 Da (data not shown) with a difference of 5278 Da
between the two values. Because GnTI-cells only add to each
N-linked glycosylation site a Man5GlcNAc2 (mass, 1361 Da),
the estimated occupancy of the potential N-linked sugars is
3.87 units per molecule, a value consistent with conjugation
by oligosaccharde at all four N-linked glycosylation sites.
Functionally, aNRXN_1-6 is fully active in binding neuroligin-1
(Figure S1B) (Boucard et al., 2005) and LRRTM2 (de Wit et al.,
2009).
Analytical Ultracentrifugation Analyses
of the Extracellular Domain of aNRXN1
Sedimentation velocity and equilibrium measurements pro-
vide complementary information useful in determining the
globularity and oligomerization state of the extracellular domain
of aNRXN1 in solution. To determine whether aNRXN_1-6 forms
reversibly self-associating oligomers, we compared sedimenta-
tion coefficient distributions extracted using the enhanced van
Holde–Weischet analysis (Demeler and van Holde, 2004) of
two different loading concentrations. This analysis shows
identical monodisperse species for both concentrations
(Figure 1C), suggesting an absence of oligomerization at these
concentrations. The same data were then analyzed by Monte1046 Structure 18, 1044–1053, August 11, 2010 ª2010 Elsevier Ltd ACarlo analysis (Demeler and Brookes, 2008) together with a
two-dimensional spectrum analysis (Brookes et al., 2010) and
genetic algorithm analysis (Brookes and Demeler, 2007) to
establish a molecular weight (Figure 1D). These analyses indi-
cated that aNRXN_1-6 has a sedimentation coefficient of
6.36 s (6.28 s, 6.39 s) and a molecular weight of 141 kDa
(136.5 kDa, 151.4 kDa), with a frictional ratio of 1.54 (1.51,
1.64), consistent with the monomeric mass of aNRXN and indic-
ative of an elongated particle (values in parenthesis are 95%
confidence intervals from the Monte Carlo analysis) (Demeler,
2009). The monomeric molecular weight was confirmed by
sedimentation equilibrium data and a fixed molecular weight
distribution analysis that gave a peak molecular weight of
140 kDa (Figure 1E). Both sedimentation velocity and
equilibrium experiments were in excellent agreement with the
expected molecular weight based on amino acid sequence
and mass spectrometry analyses.
Single Particle Electron Microscopy
aNRXN_1-6
To obtain structural information on the extracellular domain of
aNRXN1, the purified protein was negative-stained and imaged
using a transmission EM. aNRXN_1-6 particles were monodis-
perse and homogeneous in size, although individual particles
adopted a variety of conformations (Figure 2A). Approximately
6,000 particles were analyzed usingmultivariate statistics, image
classification, and averaging. In the majority of the class
averages, only five globular domains were clearly visible. We
presumed that only five of the six LNS domains were uniformly
aligned because of extensive conformational heterogeneity
intrinsic to the particles (Figure 2B). Analysis of the SDS-PAGE
profiles (data not shown) indicated that the protein was intact,
and careful inspection of the raw particle images indicate that
all six domains were always detectable but appear faintly only
in a few class averages (Figure 2C). We concluded that the
missing domain was poorly averaged because of its extensive
flexibility. These observations provide direct evidence that the
LNS1-EGF1 tandem is extremely mobile, because of the flexible
linkage of the LNS1 domain respect to the more rigid bulk of the
molecule. Molecular labeling was conducted to deduce the N- to
C-terminal orientation of the protein. We introduced a FLAG tag
at the N terminus and an HA tag at the C terminus and labeled the
purified protein with the antigen-binding fragment (Fab) against
each of the epitope tags separately. The images of the HA
Fab-tagged aNRXN_1-6 particles identified the C terminus
(LNS6) in the more structured triangular region (Figure 2D),
whereas the FLAG Fab-tagged aNRXN_1-6 identify first LNS
domain in the more elongated and flexible region (Figure 2D).
Overall, single-particle EM reveals that the extracellular domain
of aNRXN adopts a semielongated and asymmetric structure
with a shape reminiscent of the letter Y. Although this labeling
does not allow a positive identification of each LNS domain, by
their sequence in the protein, we infer that LNS domains 1–4
form the longer base of the ‘‘Y’’ and LNS5-6 the two arms.
aNRXN_2-6
To reduce the large conformational flexibility in the molecule
conferred by the first LNS domain, we removed the N-terminal
portion of the protein, which included the first LNS and EGF
domains, and the flexible linker region containing the alternativell rights reserved
Figure 2. Single-Particle Electron Microscopy Characterization of aNRXN_1-6 and aNRXN_2-6
(A) Raw data images of the particles before alignment (left panel). Scale bar, 20 nm. Boxed particle, scale bar equals 10 nm.
(B) Selection of the highest represented class averages which show only five visibly distinct domains. The panels show the breadth of flexibility of the particles.
Scale bar, 10 nm.
(C) Several averages with low representation indicate the presence of a sixth domain. Scale bar, 10 nm.
(D) Labeling of aNRXN 1-6 with Fab fragments against a C-terminal HA tag, and an N-terminal FLAG tag. Raw data images are above and a schematic repre-
sentation with arrows pointing to the identified Fab fragment is below. Scale bar, 10 nm.
(E) Left panel, raw data of aNRXN_2-6 particles; 17,321 particles were aligned and grouped into 150 class averages. Scale bar, 20 nm.
(F) Six of the highest represented averages show various conformations. Scale bar, 10 nm. See also Figure S2.
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Structure of the Extracellular Domain of aNRXN1splice site 1 (Figure 1A), generating a protein beginning at Glu280
(aNRXN_2-6). Approximately 17,000 particles of aNRXN_2-6
were analyzed, and 150 class averages were generated. The
most common class averages clearly define all five LNS domains
in aNRXN_2-6. By removing LNS1, our identification of the N and
C termini was also confirmed: the particle alignment was greatly
improved by the N-terminal truncation, and the structured trian-
gular region was maintained (Figures 2E and 2F). The difference
in particle shapes detectable in the class averages show that,
although some flexibility remains at the junctions between LNS
domains, the general Y shape is conserved. The class averages
shown in Figure 2F depict the range of conformational variability.
Although little variation is present at theN terminus of the protein,
more flexibility is adopted at the C terminus where the Y shape
can be disrupted by LNS6 being removed from LNS4. The
complete set of class averages shown in Figure S2 yields
a more comprehensive view of the conformational heterogeneity
of the extracellular domain of aNRXN1. Probably because ofStructure 18, 1044–their small size, densities corresponding to the three EGF
domains remain unresolved. Overall, it appears that aNRXN1
has a tightly packed core composed of LNS2-4 and contains
flexible regions that allow the extremities of the protein to extend
and retract freely. From a biological perspective, this mobility
could be relevant for allowing the domain to fit within the
dimensions of the synaptic cleft and interact simultaneously
with multiple binding partners. Having established the basic
two-dimensional conformation of the extracellular domain of
aNRXN1, we proceeded to reconstruct the three-dimensional
structure using solution scattering methods.
Small Angle X-Ray Scattering Analysis
of the Extracellular Domain of aNRXN1
Reproducible, high-quality scattering data for the entire
extracellular domain of aNRXN_1-6 were collected from three
independent sample preparations as well as frommonodisperse
solutions of lysozyme used as a secondary standard for1053, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 1047
Figure 3. Scattering Intensity and P(r) Functions of the aNRXN_1-6
and aNRXN_2-6
(A and C) Scattering profiles of the highest concentrations of aNRXN_1-6 and
2-6 and P(r) fits.
(B and D) P(r) functions of aNRXN_1-6 and 2-6 proteins, indicating the
maximum dimension of the particle. Statistical quality of the data in panels B
and D can be assessed by the standard error bars; some estimated errors
are smaller than the symbols. See also Table S1 and Figure S3.
Structure
Structure of the Extracellular Domain of aNRXN1calibration of scattering intensity (Krigbaum and Kugler, 1970).
Single-particle EM results show that the first LNS-EGF pair is
significantly flexible. Therefore, to simplify our structural anal-
yses and to strengthen our interpretation of the small angle
X-ray scattering (SAXS) data, experiments on the truncated
aNRXN_2-6 construct were also performed. The forward scat-
tering intensities (I(0)) and radius of gyration (Rg) of each of the
aNRXN_1-6 and aNRXN_2-6 samples were derived from the
scattering data using Guinier analysis. As expected for monodis-
perse particles in solution, excellent linear correlations were
observed in the Guinier plots for both constructs (Figure S3,
top panels), and no significant concentration-dependent change
in the Rg or I(0) values were observed (Figure S3, lower
panels). Using the known relationship I(0)/cfMW (with c in units
of mg/mL) and comparing data with that of lysozyme scattering,
estimates of themolecular weight of the scattering particles were
164–174 kDa for aNRXN_1-6, and 109–118 kDa for aNRXN_2-6,
consistent with hydrodynamic and mass spectrometric mea-
surements (for detailed tabulated results of I(0),Rg andmolecular
weight estimates, see Table S1).
Indirect Fourier transformation yields the probable interatomic
distance distribution P(r) within the scattering molecule,
providing an estimate of the maximum dimension of the particle
and its shape. The P(r) profiles for aNRXN_1-6 and aNRXN_2-6
(Figure 3), calculated using the program GNOM (Svergun,
1992), indicate that both proteins (Figures 3B and D, respec-
tively) are extended particles in solution (structurally anisotropic),
as noted by the skewed distribution of vector lengths. The
maximum dimension, Dmax, of the full-length construct is170 A˚
with an average Rg of 53.0 ± 0.3 A˚. As expected, the truncated
variant is significantly smaller, with a Dmax of 145A˚ and an
averageRg of 44.2 ± 0.6 A˚. Removing the LNS-EGF pair shortens
the maximum dimension of the protein by 25 A˚ and decreases
the radius of gyration of 9 A˚ without altering the general
shape of the P(r) profile. Despite inherent segmental flexibility,
the significantly shorter maximum dimension of the deletion
mutant aNRXN_2-6 indicates that the domains within the
LNS_2-6 region of the protein retain their extended configuration
upon removal of the LNS1-EGF1 domain pair. Taken together,
these data show that the extracellular domain of aNRXN is
monomeric in solution and free of aggregation or interparticle
interference. Thus, the scattering data fulfill the requirements
necessary for extracting accurate shape information from which
reliable three-dimensional structural models of aNRXN_1-6 and
aNRXN_2-6 can be constructed.
Three-dimensional Reconstruction of the Extracellular
Domain of aNRXN1
Using a combination of high-resolution structures and homology
models of the individual LNS and EGF subunits, rigid-body
modeling of the SAXS data enabled us to obtain independent
three-dimensional structural models of aNRXN that closely
resemble the shapes obtained with single-particle EM. The
crystal structures of LNS 2, 4, and 6 are available (Rudenko
et al., 1999; Sheckler et al., 2006; Shen et al., 2008), and
homology models of the remaining individual subunits (LNS1,
3, and 5; EGF1, 2, and 3) were built using various high-resolution
templates, as specified in Experimental Procedures. Eight
sequences, ranging between 4 and 26 residues, linking various1048 Structure 18, 1044–1053, August 11, 2010 ª2010 Elsevier Ltd ALNS and EGF domains did not have a suitable three-dimensional
template and thus were initially omitted from the calculations
performed with the program SASREF (Petoukhov and Svergun,
2005). Distance constraints were imposed between the nine indi-
vidual rigid bodies to ensure that the N and C termini of the indi-
vidual domains remain within reasonable distances during
refinement (details in Tables S2 and S3). The SASREF refine-
ments were run multiple times against scattering intensity data
from aNRXN_1-6 and aNRXN_2-6. The majority (80%) of solu-
tions converged toward a single class of Y-shapedmolecule with
LNS1/LNS2 forming the base of the Y and LNS5/LNS6 forming
the arms (Figure 4), in excellent agreement with the EM images
(Figure 2).
Approximately 11% of the mass of aNRXN_1-6 (primarily in
the linkers connecting LNS1/EGF1 and EGF1/LNS2) was not
included in the SASREF modeling, whereas only 4% of the
mass was missing for aNRXN_2-6. We therefore used the
programBUNCH that, although similar to SASREF, can addition-
ally account for contributions from regions of the model with
unknown structure. Initial BUNCH refinements were performed
using similar distance constrains as those used in SASREF
against both aNRXN_1-6 and aNRXN_2-6 data sets and the
fit to the data improved for both constructs (Figure 4A) (further
details on BUNCH refinement strategy are available in the
Supplemental Information). As expected, all of the refined
BUNCH models maintain the characteristic Y-shape obtained
by the other methods. In addition, they show the likely average
positioning of the linkers of unknown structure.
Because of the inherent flexibility of the multidomain architec-
ture, although we present the ‘‘best-fit’’ SASREF and BUNCH
models for both constructs (Figure 4A), it is most pertinent toll rights reserved
Figure 4. Rigid Body Modeling of the aNRXN_1-6
and 2-6 with the SAXS Data and aNRXN_2-6
SAXS Models Overlay on Selected EM particles
(A) Best-fitmodels of aNRXN_1-6 and aNRXN_2-6 derived
from BUNCH rigid-body refinement and their respective
fits to the data. The EGF domains are colored blue
(EGF3 is occluded in aNRXN_1-6).
(B) Structural ensembles represented as semitransparent
green surfaces and ribbons of both aNRXN constructs
generated using SASREF and BUNCH rigid body
modeling. Brackets indicate different domains of the
ensemble. For clarity, brackets and domain labels have
been omitted for some ensembles.
(C) Green and red are two different SASREF reconstruc-
tions manually superimposed to two similar class aver-
ages to show their degree of identity. Atomic models
were made using PyMol (http://www.pymol.org). See
also Tables S2 and S3.
Structure
Structure of the Extracellular Domain of aNRXN1view the results in terms of ensembles of structures that share
a common Y-shaped topology (Figures 2 and 4B). For example,
the arms of the Y (LNS5 or LNS6) can be spatially swapped
without greatly affecting the general Y-shape of the model.
Furthermore, upon comparing eachmember across the SASREF
and BUNCH ensembles, the individual domains can undergo
a limited localized tilting or rotation relative to their domainStructure 18, 1044–1053, August 11,neighbors without affecting the fits to the data.
Consequently, although the general architec-
ture of the protein is maintained, the RMSD Ca
across the ensembles is broad, ranging
from 7 to 25 A˚. Although this variability could
be due to inherent limitations in modeling a
protein with multiple domains, the solution
scattering results are consistent with the elec-
tron microscopy data that indicate individual
domains can reorient via flexible interdomain
linkers.
DISCUSSION
The small volumes and spanning dimensions of
synaptic clefts are critical for rapidity and fidelity
of synaptic transmission. With a typical span
of 24 nm between the pre- and postsynaptic
membrane, it is unclear how large multi-domain
proteins such aNRXN (1400 amino acids in its
entire extracellular domain), L1CAM (1300
amino acids), and protocadherin (1100 amino
acids), along with other large synaptic recep-
tors and channels, are structured to coexist
within the cleft and maintain synaptic structure
and function. Furthermore, the extracellular
domains of these large proteins are generally
composed of a sequential arrangement of
several individually folded domains connected
by flexible linkers, and they associate with
multiple partnering proteins. Whether these
proteins are completely flexible or have a
restricted interdomain segmental motion isunknown. The aNRXNs are not only bulky multidomain mole-
cules, but between the sixth LNS and transmembrane domains
they contain a sequence of 100 residues that is relatively
rich in Ser and Thr and shown to be O-linked glycosylated
(Ushkaryov et al., 1992). The presence of oligosaccharides,
combinedwith a relative abundance of Pro residues, presumably
rigidifies and elongates the peptide chain, as demonstrated in2010 ª2010 Elsevier Ltd All rights reserved 1049
Figure 5. Schematic Model of the Complex Between aNRXN and its
Ligands in the Context of the Synapse
The aNRXN stalk domain connects the presynaptic membrane to LNS6 of one
of the structural models obtained with SASREF. Information on the contact
surface between NLGN and LNS6 of aNRXN was taken from the available
crystal structure. Stalk domains are drawn extended because of their likely
semirigid structure. Intracellular domains of both NLGN and NRXN have no
conformational assignment. Schematic models of the other known aNRXN
ligands (dystroglycan, neurexophilin, and LRRTM2) are added to show how
multiple ligands can associate simultaneously to their respective LNS
domains. Structural models have depth cue visual information. Approximate
distances and dimensions are to scale (pre- and postsynaptic gap is main-
tained at 22 nm).
Structure
Structure of the Extracellular Domain of aNRXN1neuroligin-1 and other cell-surface receptors (Li et al., 1996;
Merry et al., 2003; Comoletti et al., 2007). The length of this single
chain tether may be advantageous to extend the sixth LNS
domain so that it can approach the center of the synaptic space,
permitting association with postsynaptic proteins such as neuro-
ligin or LRRTM2 (Comoletti et al., 2007; de Wit et al., 2009;
Ko et al., 2009). The presence of the stalk domain, however,
extends the overall length of aNRXN beyond what a semielon-
gated amino acid sequence would predict.
Sedimentation velocity and equilibrium analyses unambigu-
ously show that the extracellular domain of aNRXN is a
semielongated monomer. Although analytical ultracentrifugation
experiments employ low protein concentration (between 10 nM
and 7 mM, equivalent to 0.0014 and 1 mg/mL, respectively) that
could favor dissociation to the monomeric species, SAXS
experiments were conducted at concentrations up to6 mg/mL
(40 mM). Under these conditions, higher order oligomers
were not detected, indicating that the extracellular domain of
aNRXN, similar to b-neurexin (Comoletti et al., 2006), does not
self-associate. Thus, unless oligomerization occurs through the
short intracellular domain, aNRXN is likely present as amonomer
on the cell surface.
Single-particle EM shows that the LNS1-EGF1 pair of
aNRXN_1-6 has extensive interdomain flexibility with respect
to the rest of the protein. This flexibility is likely due to the length
of the linker (27 amino acids, S256–Y282) that contains splice
insert 1. Conversely, the excellent averaging of the particles for
aNRXN_2-6 indicates that the rest of the molecule maintains
a more stable conformation (Figure 2). The central region of the
protein shows LNS2 to 4 in a linear arrangement, whereas
LNS5 lies at various angles in relation to the previous domains.
LNS6 normally folds back on the protein, making a triangular
or Y shaped arrangement with LNS4, but displays a large degree
of flexibility.
Building on the crystal structures of LNS domains 2, 4, and 6
(Rudenko et al., 1999; Sheckler et al., 2006; Shen et al., 2008)
and from homology models for the remaining domains, we con-
structed three dimensional structures of the entire extracellular
domain of aNRXN1, including the linker regions, and optimized
them against X-ray solution scattering data. Consistent with
hydrodynamic and electron microscopy findings, the three
dimensional best-fit models show that aNRXNmaintains a semi-
elongated structure, with LNS domains 1–4 arranged linearly and
LNS 4, 5, and 6 adopting a triangular ‘‘clover leaf’’ conformation
(Figure 4). Scattering data record the time and rotationally
averaged structural information from molecules in solution,
rather than a ‘‘snap shot’’ of a single molecule on a grid as it is
observed byEM. The rotational averaging inherent to the solution
scattering experiment reduces the information content to one-
dimension and thus, when interpreting three-dimensional
models, some basic starting assumptions must be satisfied.
First, on comparing the P(r) profiles of aNRXN_1-6 and
aNRXN_2-6 and from a direct overlay of the scattering data,
a level of structural preservation must be maintained within the
LNS2-LNS6 region of the protein that is not affected by the
removal of the LNS1-EGF1 domain pair. Second, in the jelly roll
fold of the LNS domain the metal-binding pocket, where
neuroligins bind, is located at the rim of the b sheet sandwich
opposite the N and C termini (Rudenko et al., 1999) that reside1050 Structure 18, 1044–1053, August 11, 2010 ª2010 Elsevier Ltd Aclose together. Consequently when one LNS domain is con-
nected to the next (or to an EGF domain) by relatively
short5–7 amino acid linkers, as in the case of the LNS4-6, these
domains will be constrained toward a ‘‘clover leaf’’ spatial
arrangement as opposed to a linear ‘‘beads on a string’’ confor-
mation (Tisi et al., 2000; Carafoli et al., 2009). Third, although the
extracellular domain of aNRXN_1-6 could be considered
symmetrical with EGF2 at the center of a two-fold symmetry
(Figure 1A), the N and C termini identification with Fab tagging
and thedeletionconstructaNRXN_2-6yieldsapreciseorientation
of the protein. Together, the three-dimensional reconstructions
andelectronmicroscopymicrographs showextensive interaction
betweendomains2, 3, and4, thusexplaining the relative rigidity of
this part of the molecule. Consistent with the higher degree of
flexibility evident in the raw particle images in the EM micro-
graphs, fewer contacts appear betweenLNS1and2andbetween
LNS5 and 6. Together, these results indicate that the protein
maintains a stable core architecture that likely exists in an extra-
cellular milieu and anchors its biological functions (Figure 5).
Proteins comprising a large number of independently folded
domains, such as the aNRXN, laminin-G, and others are normally
flexible because interdomain motions are likely linked to
their biological activities. The high-resolution structure of LNS
1-3 of laminin a2 (Carafoli et al., 2009) shows that inter-LNS
domain linkers maybe extended and flexible. In the case of
aNRXN, multiple interacting proteins have been isolated andll rights reserved
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the second LNS domain of aNRXN (Missler et al., 1998), whereas
the neuroligins and LRRTM2 associate with the sixth LNS
domain (Ichtchenko et al., 1995; Boucard et al., 2005; de Wit
et al., 2009; Ko et al., 2009) and dystroglycan associates with
both the second and the sixth LNS domains (Sugita et al.,
2001). The mobility of LNS1 provides greater surface accessi-
bility to the second LNS domain. LNS6, belonging to the arms
of the ‘‘Y’’ shape, tends to fold back toward LNS4, creating
a more compact structure, potentially limiting the accessibility
to binding partners (Reissner et al., 2008). However, single-
particle EM data show that LNS6 retains some flexibility, and
the clover-leaf arrangement suggests that the metal binding
rim of each LNS domain is likely solvent exposed rather than
being confined to interdomain stabilization. Regarding the
decreased affinity that aNRXN shows with the neuroligins (Bou-
card et al., 2005), it is possible that the extensive flexibility and
segmental motion of LNS6 may require that optimal binding is
achieved only after a conformational change, thus acting as
a factor limiting NLGN binding.
The three-dimensional structural models of aNRXN we
present here are, to our knowledge, the first experimentally
derived models of the entire extracellular domain of the aNRXN
super-family or other LNSmodular multidomain proteins. Taking
advantage of the multiple crystal structures available of the
complex between neuroligin 1 and 4 (Fabrichny et al., 2007;
Arac¸ et al., 2007; Chen et al., 2008) with bNRXN, and using
our previous findings on the structure of the stalk domain of
the neuroligins, we assembled a model of the complex between
one of the aNRXN_1-6 models and neuroligin 1 in the context of
the synaptic cleft. In the case of aNRXN, flexibility, partial
elongation, and the clover-leaf arrangement of LNS4-6 domains
are ideal for binding multiple ligands because each LNS subunit
can associate with partnering proteins independent of the neigh-
boring domains. As shown in themodel of the complex (Figure 5),
the presence of the stalk region and the elongated nature of this
model explain how multiple ligands can bind simultaneously to
the extracellular domain of aNRXN, and how it may orient in
the synaptic cleft.
As hypothesized in an earlier work (Tabuchi and Su¨dhof,
2002), mutations in NRXN genes likely confer subtle phenotype
changes that may result in widespread dysfunction during the
development of a complex nervous system, particularly in a
polygenic disorder involving other proteins affecting neuronal
system development. In fact, new evidence indicates that varia-
tions in copy number and rare variants within the genes encoding
neurexin-1 and -3 (NRXN1 and NRXN3) contribute to ASD
susceptibility, mental retardation (Feng et al., 2006; The Autism
Genome Project Consortium, 2007; Kim et al., 2008; Yan et al.,
2008; Glessner et al., 2009), schizophrenia (Rujescu et al.,
2009), and in altering addiction and reward behaviors to nicotine
(Nussbaum et al., 2008).
EXPERIMENTAL PROCEDURES
Expression of aNRXN1
The construct encoding the secreted, soluble extracellular domain of aNRXN1
IgG fusion protein (Ig-N1a-1) (Boucard et al., 2005) was a kind gift of
Dr. Thomas Su¨dhof (Stanford, CA). We adapted this construct by introducing
a 3C protease cleavage site (LEVLFQ/GP) between residue T1309 of aNRXNStructure 18, 1044–and the beginning of the hIgG sequence. HEK293 GnTI cells were transfected
with the appropriate plasmids and were selected by growth in G418
(Geneticin, Sigma) (Comoletti et al., 2003). For protein expression, cells were
maintained at 37C and 10% CO2 in Dulbecco’s modified Eagle’s medium
containing up to 2% fetal bovine serum.
Analytical Ultracentrifugation
All analytical ultracentrifugation experiments were performed in a Beckman/
Coulter XL-I ultracentrifuge using An60Ti and An50Ti rotors at the Center for
Analytical Ultracentrifugation of Macromolecular Assemblies, San Antonio,
TX. Sedimentation equilibrium and velocity experiments were analyzed with
the UltraScan software, version 9.9, release 847 (Demeler, 2009). All samples
were run in 10 mM sodium phosphate buffer (pH 7.4) with 137 mM NaCl and
2.7 mM KCl, at 4C. Hydrodynamic corrections were made according to
Laue et al. (1992) as implemented in UltraScan.
Negative-Stain Single-Particle Electron Microscopy
Purified aNRXN1 (0.05–0.1mg/ml) in 10mMHEPES (pH 7.4) and 150mMNaCl
solution was applied to glow-discharged carbon-coated grids and was nega-
tively stained with 0.75% uranyl formate, as described elsewhere (Ohi et al.,
2004). EM images for class averageswere collected using anFEI 200KVSphera
microscope equipped with an LaB6 electron filament using low-dose proce-
dures on SO-163 Kodak film at a magnification of 50,0003 and nominal defo-
cus of1.5 mm.Micrographswere digitizedwith aNikon scanner, and particles
were selected interactively using the WEB display program. A second pass
selection of properly centered particles was done interactively, and particles
were aligned and classified by reference-based alignment and the K-means
classification (100–150 classes) using the SPIDER suite (Frank et al., 1996).
Small-Angle X-Ray Scattering Data Acquisition of aNRXN1
Data were collected from the proteins and their solvent blanks (ultrafiltrate
buffers for the aNRXN and last step dialysate for lysozyme) at 20C, using
an Anton Paar SAXSess line collimation instrument at the University of Utah
on 2D position-sensitive image plates (10 mm slit and integration width) as
described by Jeffries et al. (2008).
Structure Modeling from the Scattering Data
Rigid bodymodeling was performed using the programs SASREF and BUNCH
(Petoukhov and Svergun, 2005). Both techniques refine the domain positions
within the protein against the scattering data using calculated partial scattering
amplitudes derived from the atomic structures of the individual component
domains.
More information on some of the methods can be found in the Supplemental
Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.str.2010.06.005.
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